GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Neximmune NEXI · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 28 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Neximmune — daily NEXI Delayed
Market value
$139
Last close × shares
Volume
1.4k
Shares, 28 Oct 2026

About Neximmune

Its shares trade under the ticker NEXI. It has been listed since 12 February 2021.

Neximmune Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Gaithersburg, Maryland. The company went IPO on 2021-02-12. NexImmune, Inc. is a clinical-stage biotechnology company. The firm is engaged in developing an approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. Its product candidates include NEXI-001 in acute myeloid leukemia (AML) and NEXI-002 in multiple myeloma (MM). The firm provides Artificial Immune Modulation (AIM), which is a nanoparticle technology platform. Its AIM technology enables it to construct nanoparticles that function as synthetic dendritic cells capable of directing a specific T cell-mediated immune response. The AIM nanoparticles employ signaling proteins to deliver instructions to T cells directing a desired immune response. The Company’s T cell product candidates are designed to combine the attributes of cellular with reduced potential for toxicities. The company is also developing new AIM nanoparticle constructs and modalities for clinical evaluation in oncology and autoimmune disorders.

Figures and description from our data supplier, not checked against the company's own report.

More about Neximmune →

Latest on Neximmune

Our reporting

We have not reported on Neximmune yet.

Next results

17 Nov 2026

Due on 17 Nov 2026. Analysts expect earnings of -13.25 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Neximmune's ticker?

Neximmune trades as NEXI on its US listing, under ISIN US65344D2080.

What was Neximmune's last closing price?

0.00 on 28 Oct 2026. The figure is in USD and is never converted.

When does Neximmune next report results?

Results are expected on 17 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.